Company Filing History:
Years Active: 1991
Title: Gerald Breuleux: Innovator in Serotonin M Receptor Antagonism
Introduction
Gerald Breuleux is a notable inventor and legal representative based in Zurich, Switzerland. He has made significant contributions to the field of pharmacology, particularly in the development of serotonin M receptor antagonists. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Gerald Breuleux holds a patent for a method of inducing a serotonin M receptor antagonist effect. This patent involves the use of dicarboxylic, heterocyclic, and substituted benzoic acid alkylene bridged piperidyl amides and esters as serotonin M antagonists. This groundbreaking work has the potential to impact therapeutic approaches in treating various conditions related to serotonin receptors.
Career Highlights
Breuleux is currently associated with Sandoz GmbH, a leading global healthcare company. His role as a legal representative allows him to navigate the complexities of patent law while contributing to innovative pharmaceutical solutions. His expertise in both legal and scientific domains positions him as a valuable asset to his organization.
Collaborations
Throughout his career, Gerald has collaborated with esteemed colleagues such as Peter Donatsch and Gunter Engel. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, ultimately leading to advancements in their respective fields.
Conclusion
Gerald Breuleux exemplifies the intersection of legal expertise and scientific innovation. His contributions to the field of serotonin M receptor antagonism highlight the importance of interdisciplinary collaboration in advancing healthcare solutions. His work continues to inspire future innovations in pharmacology.